Introduction
Hepatocyte growth factor (HGF) is a heparin binding protein with roles in normal development, homeostasis and carcinogenesis (reviewed in Matsumoto and Nakamura, 1997; Rubin et al., 1993) . HGF is a potent mitogen for hepatocytes, myeloid progenitor cells, and a wide variety of epithelial and endothelial cell types (Rubin et al., 1993) . It stimulates the scatter of Madin-Darby canine kidney (MDCK) cells, and enhances motility in other epithelial and endothelial cells (Rubin et al., 1993) . HGF also stimulates branching morphogenesis and/or tubulogenesis in epithelial cells and endothelial cells in culture (Rubin et al., 1993; Montesano et al., 1998) . Several studies implicate the HGF pathway in development, and mice lacking the genes for either HGF or its receptor die in utero from severe disruption of liver and placental organization (Matsumoto and Nakamura, 1997; Schmidt et al., 1995; Uehara et al., 1995; Bladt et al., 1995) .
HGF binds and activates the c-Met transmembrane tyrosine kinase, identi®ed originally as an oncogene activated by chromosomal rearrangement (Rubin et al., 1993) . Upon ligand binding, c-Met activates phosphatidylinositol 3-kinase (PI3K) and mitogen-activated protein kinase (MAPK) through the Gab1/Grb2-SOSRas pathway (Rubin et al., 1993; Ponzetto et al., 1994; Weidner et al., 1996) . A region of c-Met that includes two phosphorylation sites in the carboxy-terminal tail, Tyr 1349 and Tyr
1356
, reportedly contains docking sites for PI3K, Grb2, Gab1, as well as other signaling molecules (Ponzetto et al., 1994 (Ponzetto et al., , 1996 Weidner et al., 1996; Zhu et al., 1994; Royal and Park, 1995; Fournier et al., 1996; Nguyen et al., 1997) . Mutation of both Tyr 1349 and Tyr 1356 in c-Met severely impaired the transforming activity of oncogenic Tpr-Met (Ponzetto et al., 1994) , while mutation of Tyr 1356 alone impaired c-Met association with Grb2, the p85 subunit of PI3K, and HGF-stimulated motility and morphogenesis (Zhu et al., 1994) . Treatment of intact cells with wortmannin blocked HGF-induced scatter and mitogenesis in epithelial cells (Royal and Park, 1995; Rahimi et al., 1996) , suggesting that c-Met activation of PI3K is required for these activities. Cell scatter also appears to require the activation of Ras (Hartmann et al., 1994) , and possibly the small GTP-binding proteins Rac and Rho (Royal et al., 1997) . Eorts to speci®cally uncouple Grb2 from c-Met by mutating Asn 1358 resulted in the loss of Tpr-Met transforming activity and HGF-stimulated MDCK cell tubulogenesis, without blocking cell scatter (Ponzetto et al., 1996; Fournier et al., 1996; Royal et al., 1997) . Gab1 is an insulin receptor substrate-1-like protein that is phosphorylated by c-Met through direct interaction with Tyr 1349 (Nguyen et al., 1997) , and Gab1 expression was sucient to induce branching morphogenesis in epithelial cells (Weidner et al., 1996) .
A naturally occurring truncated HGF isoform, HGF/NK2, is an antagonist of the mitogenic and morphogenic activities of full-length HGF (Rubin et al., 1993; Montesano et al., 1998) . While full-length HGF is a disul®de-linked heterodimer composed of a 60 kDa heavy chain and a 30 kDa light chain, HGF/ NK2 consists of only the amino-terminal domain and the ®rst two kringle domains of the HGF heavy chain. Both HGF and HGF/NK2 bind c-Met and stimulate cell scatter, but unlike HGF, HGF/NK2 lacks intrinsic mitogenic activity and antagonizes the mitogenic activity of HGF in 184B5 human mammary epithelial cells (Rubin et al., 1993) . HGF/NK2 was shown to have weak but detectable mitogenic activity on mink lung cells and Baf3 cells transfected with c-Met, although this activity required the addition of heparin (Schwall et al., 1996) . These results suggest that HGF/ NK2 may be able to stimulate DNA synthesis in some cell lines, but with far less potency than full-length HGF.
In an eort to understand the molecular basis for the dierent biological properties of full-length HGF and HGF/NK2, we characterized the postreceptor signaling pathways activated by these two HGF isoforms in 184B5 cells and the murine myeloid progenitor cell line 32D transfected with human cMet. In both cell systems, HGF induced DNA synthesis while HGF/NK2 was mitogenically inactive, but both isoforms stimulated cell motility. Both HGF and HGF/NK2 stimulated c-Met autophosphorylation, and the activation of PI3K and MAPK, suggesting that in at least some HGF target cells the activation of another, as yet undetermined, postreceptor signaling pathway is required for HGF-stimulated mitogenesis.
Results
HGF, but not HGF/NK2, stimulates DNA synthesis by 184B5 and 32D/c-Met cells
The murine myeloid progenitor cell line 32D was transfected with human c-Met cDNA and individual transfectants were cloned from neomycin-resistant mass cultures. A 32D cell clone was selected that expressed levels of c-Met comparable to that of the human mammary epithelial cell line 184B5 (Figure 1a) , for which biological responsiveness to HGF is well established (Rubin et al., 1993) , and used in all subsequent studies. The eects of HGF and HGF/ NK2 on DNA synthesis by these two cell lines was compared across a wide range of ligand concentration (Figure 1b) . HGF mitogenic activity was detectable with as little as 0.05 nM HGF in 184B5 cells, and 0.5 nM in 32D/c-Met cells, and the relative HGF potency, as indicated by the 50% maximal dose, was about tenfold higher in 184B5 cells than in 32D/c-Met cells (0.2 vs 2 nM; Figure 1b ). In contrast, even at concentrations as high as 100 nM, HGF/NK2 failed to stimulate DNA synthesis in either cell line (Figure 1b) .
Previous reports that cell-surface heparin proteoglycan modulates HGF activity (Schwall et al., 1996; Naka et al., 1993; Zioncheck et al., 1995; Sakata et al., 1997; Taipal and Keski-oja, 1997) , and the lack of cell surface heparin proteoglycan on 32D cells prompted us to examine the eects of exogenous heparin on HGFand HGF/NK2-stimulated mitogenesis in 32D/c-Met cells. The addition of heparin (10 mg/ml) with HGF increased the mitogenic potency of the latter by about threefold (Figure 1b) , suggesting that the dierence in sensitivity to HGF between 184B5 and 32D/c-Met cells was at least partially attributable to the lack of cell surface heparin proteoglycan on 32D cells. We also observed that even in the presence of added heparin, HGF/NK2 did not induce signi®cant mitogenic activity in 32D/c-Met cells (Figure 1b) . These results suggest that while heparin-proteoglycan can increase the Previous reports have shown that, despite dierences in mitogenic activity, HGF and HGF/NK2 bind to c-Met with similar anity and induce c-Met tyrosine phosphorylation (Rubin et al., 1993) . To determine whether the lack of mitogenic signaling by HGF/NK2 that we observed was attributable to less potent or attenuated activation of c-Met, we compared the doseresponse and time course of ligand-stimulated c-Met autophosphorylation by each HGF isoform. As shown in the left panel of Figure 2a . These experiments also demonstrated that in both cell systems, both HGF isoforms stimulated the same maximal level of receptor activation, despite their dierent mitogenic properties.
The time course of c-Met tyrosine phosphorylation in response to HGF or HGF/NK2 was also examined in both cell lines (Figure 2b ). In 184B5 cells, c-Met autophosphorylation was observed in 10 min or less, and reached a maximum after 30 min of stimulation with either HGF (1 nM) or HGF/NK2 (10 nM). However, receptor activation was sustained for 60 min in response to HGF, but was not detectable after 30 min in HGF/NK2-treated cells (Figure 2b, left panel) . In 32D/c-Met cells, maximal receptor activation occurred in 10 min or less in response to HGF (2.7 nM) or HGF/NK2 (3.7 nM; Figure 2 , right panel). Receptor activation was detectable for 60 mins by both HGF isoforms in this cell system. Together these results suggest that the lack of mitogenic activity of HGF/NK2 is not attributable to its inability to induce maximal and/or sustained receptor activation.
Both HGF and HGF/NK2 activate MAPK
The ability of HGF/NK2 to stimulate c-Met tyrosine phosphorylation to the same extent as HGF in both cell systems, and with similar time course and duration as HGF in 32D/c-Met cells, suggested that the dierence in mitogenicity between HGF and HGF/ NK2 may be attributable to events that occur after receptor activation. MAPK is activated in response to a wide variety of growth factors and cytokines including HGF, and has been implicated in the growth and transformation of a variety of cell types (Rubin et al., 1993; Cowley et al., 1994; Mansour et al., 1994; Hunter, 1997) . The importance of this pathway in mitogenic signaling prompted us to investigate MAPK activation by HGF and HGF/NK2. Immuno- In each experiment equal amounts of lysed cell protein were immunoprecipitated with anti-c-Met, followed by immunodetection using antipY (panels labeled`a-pY'). To control for minor variations in gel loading, immunoblots were then stripped by incubating in 2% SDS+100 mM DTT in PBS for 2 h at 508C with multiple buer changes. The amount of p145 and p170 c-Met in each lane (panels labeled`a-c-Met') was observed after blots were re-probed with anti-c-Met with chemiluminescent detection blots of lysates from control and HGF-treated 184B5 cells with an antibody against active MAPK revealed an increase in the levels of p44 and p42 detected within 3 min that peaked at 30 min (Figure 3a , left panel). After 60 min, the activation of both proteins had decreased, although both were still clearly activated relative to untreated control cells. The p44 and p42 MAPK activation pro®les observed by immunoblotting were consistent with the pro®le of MAPK activity observed in vitro after ERK1 immunoprecipitation from HGF-treated 184B5 cells (Figure 3b, left panel) . In contrast, both assay methods showed that treatment of 184B5 cells with HGF/NK2 caused only transient MAPK activation, which peaked at 10 min and returned to control levels within 30 min (Figure 3a and b). In both assays, HGF/NK2-stimulated MAPK activation was also of lower magnitude than that observed in response to HGF. Interestingly, these data correlated directly with the potency and duration of cMet activation by each of the two HGF isoforms in this cell line.
A general correlation between ligand-stimulated receptor and MAPK activation was also observed in 32D/c-Met cells. MAPK activation by either HGF isoform in 32D/c-Met was maximal at 10 min and declined thereafter (Figure 3a and b, right panels); MAPK activity in vitro was signi®cantly diminished after 20 min (Figure 3b , right panel). The markedly dierent temporal pro®les of HGF-stimulated MAPK activation in the two cell systems studied here suggest that HGF mitogenic potency is independent of the duration of MAPK activation. Most importantly, in this cell system HGF/NK2 stimulated almost sixfold higher MAPK activation than HGF (Figure 3a and b, right panels), which suggests that ligand-stimulated MAPK activation is not sucient for mitogenesis.
In light of a recent report implicating the MAPK family member p46 SAPK/JNK in transformation mediated by the Met oncogene (Rodrigues et al., 1997) , we extended our investigation to determine whether this enzyme, as well the MAPK known as p38 HOG-1, was activated in response to treatment of 184B5 or 32D/c-Met cells with HGF or HGF/NK2. HGF, but not HGF/NK2, stimulated modest, transient activation of p46 SAPK/JNK in 184B5 cells, while neither HGF isoform stimulated the activation of this pathway in 32D/c-Met cells (data not shown). p38 HOG-1 was not activated by either HGF isoform in 184B5 cells, but was modestly activated by both HGF and HGF/NK2 in 32D/c-Met cells (data not shown). While not inconsistent with the pattern of p42/p44 MAPK activation by HGF isoforms observed in these cell models, these data suggest that neither SAPK/JNK nor HOG-1 is universally required for HGF-stimulated DNA synthesis.
Both HGF and HGF/NK2 stimulate PI3K-dependent cell motility
Upon its activation by HGF, c-Met has been shown to associate with, and activate, PI3K in A549 lung carcinoma cells (Rubin et al., 1993) . Activation of PI3K has been shown to be required for HGF-induced mitogenesis in SP1 mammary carcinoma cells and Mv1Lu lung epithelial cells (Rahimi et al., 1996) , and for HGF-induced scatter in MDCK cells (Royal and Park, 1995) . The demonstrated importance of PI3K activation in HGF-stimulated mitogenesis and motogenesis prompted us to compare the activation of PI3K by HGF and HGF/NK2 in 184B5 and 32D/c-Met cells, and to examine whether this activity was essential for ligand-stimulated cell motility.
Both HGF isoforms activated PI3K within 3 min in both cells types, and activity remained higher than control levels for at least 30 min (Figure 4a) . In 184B5 cells, the magnitude of initial PI3K activation stimulated by HGF was approximately twofold greater than that stimulated by HGF/NK2, whereas in 32D/cMet cells both isoforms elicited equivalent levels of PI3K activity (Figure 4a ). In both cell types, the relative abilities of each HGF isoform to stimulate cell motility correlated directly with their abilities to activate PI3K. In 184B5 cells, HGF stimulated cell motility about fourfold more potently that HGF/NK2, while in 32D/c-Met cells, both ligands stimulated motility with equal potency (Figure 4b ).
Ligand-stimulated motility in both cell types was wortmannin-sensitive, reaching a maximum of 495% inhibition in 184B5 cells and 460% inhibition in 32D/ c-Met cells, regardless of which HGF isoform initiated the response (Figure 4b ). However, ligand-stimulated motility could not be completely blocked in 32D/c-Met cells even at relatively high doses of wortmannin, suggesting that the relative importance of PI3K activation to motogenesis may be cell-speci®c. The sensitivity of ligand-stimulated motility to the MEK1 inhibitor PD98059 was also cell-type speci®c: approximately 50% inhibition of motility was observed in 184B5 cells regardless of the ligand initiating the response, while this drug had no signi®cant eect on motility in 32D/c-Met cells (Figure 4b ). The failure of PD98059 to completely block motility in 184B5 cells suggests that MEK1 activation may contribute to ligand-stimulated motogenesis, but is not essential.
Discussion
The truncated, alternative HGF isoform HGF/NK2 elicits a subset of the biological responses stimulated by the full-length protein: while HGF induces mitogenesis, motogenesis, and morphogenesis, HGF/NK2 stimulates only cell motility (Rubin et al., 1993; Stahl et al., 1997) . This dierence in biological eect is not attributable to obvious dierences in the way these isoforms interact with c-Met: both isoforms compete for occupancy of the same site; experiments using properly-folded, prokaryotically expressed HGF/NK2 suggest that its receptor binding anity is only 3 ± 10-fold lower than that of HGF; and both isoforms activate the c-Met tyrosine kinase (Rubin et al., 1993; Stahl et al., 1997) . Most growth factor-receptor interactions conform to a model in which the extracellular domain represses the activity of the kinase, and ligand binding (or removal of the extracellular domain) switches the receptor kinase to a fully active state (Shoelson et al., 1988) . In contrast, these observations suggest that c-Met can exist in at least three states: repressed, partially activated, or fully activated, depending on which ligand isoform is bound. HGF/NK2-c-Met interaction provides an opportunity to de®ne these states, and to identify downstream signaling pathways that are activated in each condition. Toward the latter goal, we have compared receptor, PI3K, and MAPK activation by HGF and HGF/NK2 in epithelial and hematopoietic cell systems expressing similar levels of c-Met protein, and correlated these with mitogenic and motogenic biological responses.
In both cell systems HGF was a potent mitogen, while in contrast, HGF/NK2 was completely devoid of this activity. Despite the similar mitogenic responses of these cell lines to each HGF isoform, clear dierences in the pattern of ligand-stimulated c-Met autophosphorylation between the two cell lines were observed. In 184B5 cells, HGF showed tenfold greater potency than HGF/NK2, although both isoforms stimulated the same maximum level of receptor activation. The time course of c-Met autophosphorylation in response to HGF/NK2 was also attenuated in this cell line relative to HGF. In contrast, both HGF isoforms stimulated receptor activation in 32D/c-Met cells with similar potency, maximum levels, and temporal pro®les. Together these results suggest that the inability of HGF/NK2 to stimulate DNA synthesis is not attributable to a failure to stimulate or sustain maximum receptor autophosphorylation, and that neither the apparent level or duration of receptor autophosphorylation are predictive of mitogenic signaling.
In 184B5 cells, the magnitude and duration of MAPK activation correlated directly with the potency of each HGF isoform to activate c-Met and stimulate DNA synthesis: HGF stimulated sustained MAPK activation (*60 min), while HGF/NK2 elicited transient (*30 min) and somewhat weaker MAPK activation. While alone these data suggest an important link between potent, sustained MAPK activation and mitogenesis, the results obtained by applying the same experimental approach to a dierent cell system support the opposite conclusion. In 32D/cMet cells, both HGF and HGF/NK2 induced transient MAPK activation (maximal at 10 min) and HGF/NK2 stimulated almost fourfold higher MAPK activation. Therefore, although the greater magnitude and duration of HGF-stimulated MAPK activity, relative to HGF/NK2, correlated with mitogenic activity in 184B5 cells, the MAPK activity pro®les observed in 32D/c-Met cells suggest that neither sustained nor maximal MAPK activity are universally required or sucient for HGF-induced mitogenesis.
The general independence of mitogenic potency and MAPK activation that we observed is consistent with other cell-speci®c correlations between growth or dierentiation and the duration of MAPK activation. In mesangial cells, sustained MAPK activation (460 min) in response to platelet-derived growth factor-BB or insulin correlated with proliferation, whereas transient MAPK activation elicited by angiotensin II correlated with hypertrophy (Huwiler et al., 1995; Verlhac et al., 1994) . Sustained MAPK activation has also been associated with cell proliferation stimulated by GM-CSF in Rat1 ®broblasts (Ishihara et al., 1997) . However, constitutive or sustained activation of MAPK in nerve growth factor-treated PC12 cells was associated with differentiation, while transient MAPK activation (520 min) in response to epidermal growth factor correlated with proliferation (Cowley et al., 1994; Mansour et al., 1994) . Also, two potent mitogens in Swiss 3T3 cells, epidermal growth factor and bombesin, resulted in activation of MAPK for only 10 min (Okuda et al., 1992) .
The PI3K pathway controls a number of cellular processes including cytoskeletal organization, cell growth, and survival (Ueno et al., 1997; Kubota et al., 1998; Kennedy et al., 1997) . PI3K activity is upregulated in response to most growth factors (Varticovski et al., 1994) , and PI3K activated through naturally occurring mutations (Jimenez et al., 1998) , as well as a retrovirus-encoded PI3K catalytic subunit (Chang et al., 1997) , can cause cell transformation. We observed that both HGF isoforms rapidly activated PI3K, and that in both cell types, the relative abilities of each HGF isoform to stimulate cell motility correlated directly with their abilities to activate PI3K. The complete PI3K dependence of ligandstimulated motility in 184B5 cells is consistent with the requirement of PI3K for HGF-stimulated MDCK cell scatter (Royal and Park, 1995; Royal et al., 1997) . The sensitivity of 184B5 motility to PD90859 suggests that MEK1 activity may also contribute to HGFstimulated motogenesis in epithelial cells, and is consistent with previous work showing that a dominant-negative Ras mutant inhibited MDCK cell scatter (Hartmann et al., 1994) . Interestingly, the failure of wortmannin to completely inhibit ligandstimulated motility in 32D/c-Met cells, and the lack of eect of PD90859, suggests that other pathways may be critical for the motogenic response to HGF in nonepithelial target cells.
We have observed that HGF/NK2 is not mitogenic in 32D/c-Met cells, despite the fact that this isoform is capable of stimulating receptor autophosphorylation, MAPK, and PI3K activation to at least the same extent as HGF. Thus activation of MAPK and PI3K pathways, although required for HGF-induced mitogenesis in epithelial cells, is not sucient for mitogenicity in 32D/c-Met cells. Using mutants of insulin-like growth factor-1 (IGF-1) receptor, Scrimgeor et al. (1997) also found that activation of both MAPK and PI3K pathways was insucient for IGF-1-induced mitogenesis and tumorigenesis. That study, and the results we report here, suggest that the activation of other, yet unidenti®ed pathway(s) by HGF, but not by HGF/NK2, may be required for mitogenic signaling through these tyrosine kinase receptors. Interestingly, there is evidence that the additional pathway activated by IGF-1 may be distinct from that downstream of c-Met. Previous work from our laboratory has demonstrated mitogenic synergy between a group of growth factors (e.g. ®broblast growth factor and epidermal growth factor) and IGF-1 in cultured keratinocytes (Falco et al, 1988; Aaronson et al., 1989) . Thus in this system, IGF-1 activates at least one pathway that is not activated by the other growth factors. More recent, unpublished results suggest that HGF and IGF-1 are also synergistic in this system (Rubin et al. manuscript in preparation) . Current eorts are aimed at identifying pathways that are dierentially activated by HGF and HGF/NK2 through c-Met, and de®ning the mechanism(s) by which alternative receptor activation states are elicited by the binding of dierent HGF isoforms.
Materials and methods

Materials
Rabbit polyclonal anti-human c-Met (C-28) and anti-Erk 1 antibodies were obtained from Santa Cruz Biotechnology. Mouse monoclonal antibodies to phosphotyrosine (4G10) were purchased from Upstate Biotechnology, Inc. Rabbit polyclonal phospho-speci®c antibodies to MAPK were purchased from New England Biolabs. Human HGF and the cDNA for human c-Met in the pMOG vector were gifts from G Vande Woude. The pCEV27 vector was kindly provided by T Miki. P81 phosphocellulose disks were purchased from Gibco and the myelin basic protein (MBP) peptide (Ala-Pro-Arg-Thr-Pro-Gly-Gly-Arg-Arg) was from Phoenix Pharmaceuticals, Inc. Heparin (porcine intestine) was from Sigma. HGF/NK2 was produced in a bacterial expression system, puri®ed and refolded as previously described .
Cultured cell lines and cDNA transfections
The human mammary epithelial cell line 184B5 (referred to previously as B5/589; 2) was maintained in Roswell Park Memorial Institute (RPMI) 1640 medium (Gibco)+10% fetal bovine serum (FBS) and 5 ng/ml epidermal growth factor (Becton Dickinson). The murine IL-3-dependent cell line 32D was cultured in RPMI 1640+10% FBS and 5% WEHI-3B conditioned medium as a source of IL-3. 32D/cMet cells were generated by co-transfection of 32D cells with pMOG human c-Met cDNA and the neomycin-resistance encoding pCEV27 cDNA by electroporation as previously described (Pierce et al., 1988) . Cells were selected in G418 and c-Met expression in stable cell lines was detected by immunoblotting.
Cell proliferation assays
Mitogenic assays were performed using 184B5 cells or 32D/cMet cells as previously described (Pierce et al., 1988; Cioce et al., 1996) . Brie¯y, cells were incubated in serum-free medium for 24 h (184B5) or 4 h (32D/c-Met) before the addition of growth factors for 16 h (184B5) or 36 h (32D/c-Met). Cells were incubated with [ 
Immunoblot analysis
For anti-phosphotyrosine (anti-pY) and anti-active MAPK immunoblot experiments, cells were serum-deprived for 16 h (184B5) or 4 h (32D/c-Met) prior to growth factor treatment at 378C. Anti-active MAPK and anti-c-Met immunoblotting was performed on cell lysates after SDS ± PAGE; anti-pY immunoblotting was performed after lysates were immunoprecipitated with anti-c-Met. For these experiments, cells were extracted in lysis buer (50 mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid (HEPES), pH 7.4, 1% Triton X-100, 50 mM NaCl, 50 mM NaF, 10 mM sodium pyrophosphate, 1 mM sodium orthovanadate, 5 mM EDTA, 1 mM PMSF, and 10 mg/ml each aprotinin and leupeptin) and lysates were cleared by centrifugation. Equal amounts of protein (300 mg) were immunoprecipitated with antiserum (1 mg) and GammaBind Plus Sepharose (Pharmacia Biotech) for 2 h at 48C. Proteins were separated by SDS ± PAGE and transferred to Immobilon-P membrane (Millipore). Membranes were blocked in PBS+5% BSA at 378C for 2 h, and probed with primary antibodies in Tween+Tris buered saline (TTBS) (20 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.05% Tween 20)+0.5% BSA for 3 h at room temperature. Immunoreactive bands were visualized using secondary antibodies and enhanced chemiluminescence (Amersham Corp.). To control for minor variations in gel loading, immunoblots were then stripped by incubating in 2% SDS+100 mM DTT in PBS for 2 h at 508C with multiple buer changes. The amount of p145 and p170 c-Met in each lane was observed after blots were re-probed with anti-c-Met with chemiluminescent detection.
MAPK assays
184B5 and 32D/c-Met cells, treated with HGF or HGF/NK2, were extracted at 48C in lysis buer, and lysates were cleared by centrifugation, then immunoprecipitated (250 mg protein) with anti-Erk 1 and GammaBind Sepharose for 2 h 48C. The beads were washed twice with lysis buer, once with 100 mM Tris, pH 7.5, 0.5 M LiCl, and once in kinase reaction buer (12.5 mM MOPS, pH 7.5, 12.5 mM b-glycerophosphate, 7.5 mM MgCl 2 , 0.5 mM EGTA, 0.5 mM NaF, and 0.5 mM sodium orthovanadate). Kinase reactions contained 1 mCi [g-32 P]ATP, 20 mM ATP, 2 mM MBP peptide, 3.3 mM dithiothreitol (DTT) in kinase buer, and were performed at 308C for 30 min. Samples were spotted in triplicate on P81 disks, washed in 1% cold phosphoric acid, then in ethanol. Phosphorylation of MBP peptide was determined by liquid scintillation counting.
PI3K assays
PI3K assays were performed as previously described (Wang et al., 1992) . Brie¯y, cells were serum-deprived 4 h prior to treatment with HGF or HGF/NK2. Cells were washed with ice cold PBS containing 0.25 mM diisopropyl¯uorophosphate (DFP), and then lysed in 20 mM HEPES, pH 7.5, 1% NP-40, 10 mM EGTA, 40 mM b-glycerophosphate, 2.5 mM MgCl 2 , 10% glycerol, 1 mM DTT, 2 mM sodium orthovanadate, 1 mM PMSF, 1 mg/ml aprotinin, 1 mg/ml leupeptin and 4 mM diisopropyl¯uorophosphate (DFP). Lysates were immunoprecipitated 4 h at 48C with GammaBind Sepharose and antipY. Immunoprecipitates were washed three times in PBS+1 mM Na 3 VO 4 , 1% NP-40, twice with 0.5 M LiCl, 100 mM Tris, pH 7.6, and twice with 25 mM Tris, pH 7.5+100 mM NaCl and 1 mM EDTA. Phosphatidylinositol (Avanti Polar Lipids, Inc.) was added to a ®nal concentration of 0.2 mg/ml. Reactions were initiated by the addition of 10 mCi [g-32 P]ATP, 1 mM ATP and 5 mM MgCl 2 , ®nal concentrations. Reactions were terminated by the addition of 1 N HCl, extracted with organic solvents, and subjected to thin layer chromatography and autoradiography.
Cell migration assays 185B5 cell migration was assayed using Biocoat Cell Environments control inserts with 8.0 micron pore size (Becton Dickinson). The lower chamber contained RPMI+0.1% FBS, to which growth factors or inhibitors were added. Cells were trypsinized, washed in RPMI+0.1% FBS, added to the upper chamber at a ®nal density of 2610 5 cells/ml, and incubated for 16 h at 378C. Cells were ®xed and stained using Di-Quik (Dade Diagnostics of PR Inc.), and number of cells that had traversed the membrane were counted using low-power bright®eld microscopy. The dierence in this number between untreated and treated cells is shown on the y-axis as`Fold Increase' in migration. 32D/c-Met cell migration was assayed using a modi®ed Boyden chamber with 5 mm pore size Nucleopore ®lters (Corning) as described previously (Uren et al., 1994) . Growth factors or inhibitors were added to the lower chamber, and 32D/c-Met cells washed in serum-free medium were applied to the upper chamber, at a ®nal density of 2610 6 cells/ml, and incubated for 7 h at 378C. Cells were counted and migration was quantitated as described for 184B5 cells.
